EYE — Nova Eye Medical Cashflow Statement
0.000.00%
Last trade - 00:00- AU$58.98m
- AU$57.58m
- AU$17.13m
- 70
- 25
- 84
- 63
Annual cashflow statement for Nova Eye Medical, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2019 June 30th | 2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Changes in Working Capital | 0.061 | 0.858 | 0.027 | 0.041 | 0.489 |
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -4.21 | 5.4 | -13.1 | -4.72 | -6.82 |
| Capital Expenditures | -1.25 | -0.943 | -0.809 | -3.72 | -0.567 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -2.25 | 89.3 | -2.17 | -0.819 | -0.13 |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -3.49 | 88.3 | -2.98 | -4.54 | -0.697 |
| Financing Cash Flow Items | 0 | — | — | — | — |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -0.109 | -13.3 | -61.6 | -0.402 | 6.82 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -7.88 | 80.5 | -77.8 | -9.8 | -0.581 |